Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 8,617-8,628 of 23,847
Drug study icon
TerminatedNCT01670071

Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function for schizophrenia

This study was terminated in Taiwan. It is testing Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function for schizophrenia.

Multiple locations, including Bali Township, Taipei County
SchizophreniaDrugFrom 20 Years to 60 Years
Countries
Taiwan
Sponsor
Johnson & Johnson Taiwan Ltd
Condition
Schizophrenia
Drug study icon
CompletedNCT00490971

Effectiveness of Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Bipolarity

This study is completed in the United States, in France, in Bulgaria, .... It is testing Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo for Bipolarity.

Multiple locations, including Scottsdale
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, France, Bulgaria, ...
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.